<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04100863</url>
  </required_header>
  <id_info>
    <org_study_id>ProgenaBiome-006</org_study_id>
    <nct_id>NCT04100863</nct_id>
  </id_info>
  <brief_title>A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism</brief_title>
  <official_title>A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProgenaBiome</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ProgenaBiome</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to correlate microbiome sequencing data with information provided by
      patients and their medical records regarding autism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this Research Study is to better understand how the genetic information in
      subject's microbiome correlates to the information provided in surveys and in medical records
      regarding autism.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2020</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Correlation of Microbiome to Autism via Relative Abundance Found in Microbiome Sequencing</measure>
    <time_frame>1 year</time_frame>
    <description>Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific Autism Spectrum Disorders</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Validation of Sequencing Methods</measure>
    <time_frame>1 year</time_frame>
    <description>To validate the methods used to sequence samples</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Autism</condition>
  <condition>Autism Spectrum Disorder</condition>
  <condition>Autistic Disorder</condition>
  <condition>Autism, Akinetic</condition>
  <condition>Autism; Atypical</condition>
  <condition>Autism; Psychopathy</condition>
  <condition>Autism Fragile Syndrome X</condition>
  <condition>Autism With High Cognitive Abilities</condition>
  <condition>Autism-Related Speech Delay</condition>
  <condition>Autism, Susceptibility to, 6</condition>
  <condition>Autism Spectrum Disorder High-Functioning</condition>
  <condition>Autistic Thinking</condition>
  <condition>Autism, Susceptibility to, X-Linked 6</condition>
  <condition>Autistic Behavior</condition>
  <arm_group>
    <arm_group_label>Individuals with Autism</arm_group_label>
    <description>Individuals who have been diagnosed with autism</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>There is no intervention for this study.</description>
    <arm_group_label>Individuals with Autism</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals ages 6 and older who have been diagnosed with Autism
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent by parent or legally authorized representative

          2. Male or female patients age 6 and older.

          3. Diagnosis of autism per DSM-V criteria (See appendix)

        Exclusion Criteria:

          1. Refusal by parent or legally authorized representative to sign informed consent form

          2. Treatment with antibiotics within 2 weeks prior to screening

          3. Treatment with probiotics within 6 weeks prior to screening

          4. History of bariatric surgery, total colectomy with ileorectal anastomosis or
             proctocolectomy.

          5. Postoperative stoma, ostomy, or ileoanal pouch

          6. Participation in any experimental drug protocol within the past 12 weeks

          7. Treatment with total parenteral nutrition

          8. Any clinically significant evidence of disease that could interfere with the subject's
             ability to enter the trial

          9. Inability of parent or legally authorized representative to adequately communicate
             with the investigator or their respective designee and/or comply with the requirements
             of the entire study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabine Hazan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ProgenaBiome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabine Hazan, MD</last_name>
    <phone>8053390549</phone>
    <phone_ext>8</phone_ext>
    <email>sabinehazan@aim.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordan Daniels, MS</last_name>
    <phone>8053390549</phone>
    <email>msjordandaniels@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ProgenaBiome</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Hazan, MD</last_name>
      <phone>805-339-0549</phone>
      <email>sabinehazan@aim.com</email>
    </contact>
    <contact_backup>
      <last_name>Jordan Daniels, MS</last_name>
      <phone>805-339-0549</phone>
      <email>msjordandaniels@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sabine Hazan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 20, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Language Development Disorders</mesh_term>
    <mesh_term>Akinetic Mutism</mesh_term>
    <mesh_term>Fragile X Syndrome</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Only aggregated and deidentified data will be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

